Llwytho...
Mitochondrial apoptosis and BH3 mimetics
The BCL2-selective BH3 mimetic venetoclax was recently approved for the treatment of relapsed, chromosome 17p-deleted chronic lymphocytic leukemia (CLL) and is undergoing extensive testing, alone and in combination, in lymphomas, acute leukemias, and solid tumors. Here we summarize recent advances i...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | F1000Res |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
F1000Research
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5133681/ https://ncbi.nlm.nih.gov/pubmed/27990281 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.9629.1 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|